Current MRI techniques are susceptible to underestimation of the true tumour volume, with MRIguided therapies potentially improved through the utilisation of molecular MRI targeting tumour markers.
For more information on Ferronova’s recent #prostatecancer study:
https://lnkd.in/gda8Z2YK
